{"url_path":"/sec/derm/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1867066/0001104659-26-060297-index.html","accession_number":"0001104659-26-060297","cik":"0001867066","ticker":"DERM","issuer_name":"Journey Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1867066/0001104659-26-060297-index.html","primary_entity_key":"0001867066","primary_entity_name":"Journey Medical Corp"},"word_count":378,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\n**Exhibit No.**\n\n  ​ ​ ​\n\n**Description**\n\n3.1\n\n​\n\n[Fourth Amended and Restated Certificate of Incorporation, filed as Exhibit 3.1 to Form 8-K, filed on June 26, 2025 and incorporated herein by reference.](https://www.sec.gov/Archives/edgar/data/1867066/000110465925063032/tm2519010d1_ex3-1.htm)\n\n3.2\n\n​\n\n[Amended and Restated Bylaws of Journey Medical Corporation, filed as Exhibit 3.2 to Form 10-K, filed on March 28, 2022 and incorporated herein by reference.](https://www.sec.gov/Archives/edgar/data/1867066/000141057822000558/derm-20211231xex3d2.htm)\n\n4.1\n\n​\n\n[Form of Common Stock Certificate, filed as Exhibit 4.1 to Form S-1, filed on October 22, 2021 and incorporated herein by reference.](https://www.sec.gov/Archives/edgar/data/1867066/000110465921128950/tm2122275d9_ex4-1.htm)\n\n31.1\n\n[Certification of Chief Executive Officer of Journey Medical Corporation pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 13, 2026.**](derm-20260331xex31d1.htm)\n\n31.2\n\n[Certification of Principal Financial Officer of Journey Medical Corporation pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 13, 2026.**](derm-20260331xex31d2.htm)\n\n32.1\n\n[Certification of Chief Executive Officer of Journey Medical Corporation pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated May 13, 2026.***](derm-20260331xex32d1.htm)\n\n32.2\n\n[Certification of Principal Financial Officer of Journey Medical Corporation pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated May 13, 2026.***](derm-20260331xex32d2.htm)\n\n101\n\nThe following financial information from the Company’s quarterly report on Form 10-Q for the period ended March 31, 2026, formatted in Inline Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statement of Stockholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to the Condensed Consolidated Financial Statements (filed herewith).**\n\n104\n\n​\n\nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).**\n\n**   Filed herewith.\n\n*** Furnished herewith.\n\n​\n\n26\n\n[Table of Contents](#TOC)\n\nSIGNATURES\n\nPursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n​\n\n**Journey Medical Corporation**\n\n**(Registrant)**\n\nDate: May 13, 2026\n\nBy:\n\n/s/ Claude Maraoui\n\nClaude Maraoui\n\nPresident and Chief Executive Officer\n\n(Principal Executive Officer)\n\n​\n\n​\n\nDate: May 13, 2026\n\nBy:\n\n/s/ Joseph Benesch\n\nJoseph Benesch\n\nChief Financial Officer\n\n(Principal Financial Officer)\n\n​\n\n​\n\n​\n\n27"}